PURPOSE: Single-agent histone deacetylase inhibitors (HDACi) have limited clinical activity in human leukemia. Although the way HDACi exert their antileukemia effect is not fully understood, it is accepted that induction of apoptosis is important. We hypothesized, therefore, that combination of an HDACi with a proapoptotic agent, such as the Bcl-2 homology domain-3 mimetic GX15-070, could result in enhanced antileukemia activity. EXPERIMENTAL DESIGN: We analyzed the cellular and molecular effects of two different HDACi (MGCD0103 and vorinostat) in combination with GX15-070 in leukemia cell lines and primary acute myelogenous leukemia cells. RESULTS: We showed that the combination had synergistic antileukemia effect both in leukemia cell lines and in primary acute myelogenous leukemia cells. Using molecular markers and electron microscopy, we observed that in addition to apoptosis, autophagy accounts for the nonapoptotic decrease in cell viability, an effect that could be inhibited by chloroquine, an inhibitor of autophagy. Finally, we established a role for calpain activity in the induction of both autophagy and apoptosis by this combination. CONCLUSIONS: The combination of an HDACi and GX15-070 has synergistic antileukemia activity, and the effect is mediated by induction of apoptosis and autophagy. The combination should be studied in clinical trials of leukemia and the role of autophagy in leukemia therapy needs to be better understood. (c) 2010 AACR.
PURPOSE: Single-agent histone deacetylase inhibitors (HDACi) have limited clinical activity in humanleukemia. Although the way HDACi exert their antileukemia effect is not fully understood, it is accepted that induction of apoptosis is important. We hypothesized, therefore, that combination of an HDACi with a proapoptotic agent, such as the Bcl-2 homology domain-3 mimetic GX15-070, could result in enhanced antileukemia activity. EXPERIMENTAL DESIGN: We analyzed the cellular and molecular effects of two different HDACi (MGCD0103 and vorinostat) in combination with GX15-070 in leukemia cell lines and primary acute myelogenous leukemia cells. RESULTS: We showed that the combination had synergistic antileukemia effect both in leukemia cell lines and in primary acute myelogenous leukemia cells. Using molecular markers and electron microscopy, we observed that in addition to apoptosis, autophagy accounts for the nonapoptotic decrease in cell viability, an effect that could be inhibited by chloroquine, an inhibitor of autophagy. Finally, we established a role for calpain activity in the induction of both autophagy and apoptosis by this combination. CONCLUSIONS: The combination of an HDACi and GX15-070 has synergistic antileukemia activity, and the effect is mediated by induction of apoptosis and autophagy. The combination should be studied in clinical trials of leukemia and the role of autophagy in leukemia therapy needs to be better understood. (c) 2010 AACR.
Authors: Y Kabeya; N Mizushima; T Ueno; A Yamamoto; T Kirisako; T Noda; E Kominami; Y Ohsumi; T Yoshimori Journal: EMBO J Date: 2000-11-01 Impact factor: 11.598
Authors: Nicholas Mitsiades; Constantine S Mitsiades; Paul G Richardson; Ciaran McMullan; Vassiliki Poulaki; Galinos Fanourakis; Robert Schlossman; Dharminder Chauhan; Nikhil C Munshi; Teru Hideshima; Victoria M Richon; Paul A Marks; Kenneth C Anderson Journal: Blood Date: 2003-01-16 Impact factor: 22.113
Authors: M Tewari; L T Quan; K O'Rourke; S Desnoyers; Z Zeng; D R Beidler; G G Poirier; G S Salvesen; V M Dixit Journal: Cell Date: 1995-06-02 Impact factor: 41.582
Authors: Samy A F Morad; Matthew R MacDougall; Noha Abdelmageed; Li-Pin Kao; David J Feith; Su-Fern Tan; Mark Kester; Thomas P Loughran; Hong-Gang Wang; Myles C Cabot Journal: Exp Cell Res Date: 2019-05-18 Impact factor: 3.905
Authors: Michele Cea; Antonia Cagnetta; Marco Gobbi; Franco Patrone; Paul G Richardson; Teru Hideshima; Kenneth C Anderson Journal: Curr Pharm Des Date: 2013 Impact factor: 3.116
Authors: Xiaoyi Chen; Jason Clark; Mark Wunderlich; Cuiqing Fan; Ashley Davis; Song Chen; Jun-Lin Guan; James C Mulloy; Ashish Kumar; Yi Zheng Journal: Autophagy Date: 2017-02-15 Impact factor: 16.016